Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charles Bowkley

Diagnostic Radiology Casper, WY Medical Doctor

NPI 1528286911 CMS profile 204917

419 S Washington St, Suite 101, Casper, WY 82601

Open in the dashboard

General payments

$2,717

45 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Charles Bowkley of Casper, WY is reported in the CMS Open Payments database as having received $2,717 across 45 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $313 6
2024 General $597 9
2023 General $554 9
2022 General $629 13
2021 General $26 1
2020 General $425 3
2019 General $172 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charles Bowkley
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Charles Bowkley were reported at $313. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Charles Bowkley Diagnostic Radiology median Middle half National median
2019 $172 $108 $29–$318 $163
2020 $425 $65 $21–$252 $114
2021 $26 $92 $24–$292 $132
2022 $629 $104 $29–$294 $149
2023 $554 $110 $29–$337 $160
2024 $597 $113 $30–$356 $164
2025 $313 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $1,161 13 payments
  2. Ethicon US, LLC $303 6 payments
  3. AngioDynamics, Inc. $288 4 payments
  4. Siemens Medical Solutions USA, Inc. $192 4 payments
  5. Hologic Inc $150 3 payments
  6. Penumbra, Inc. $146 2 payments
  7. Cook Medical LLC $123 1 payment
  8. Terumo Medical Corporation $76 1 payment
  9. Hologic, LLC $63 1 payment
  10. DePuy Synthes Sales Inc. $41 2 payments
  11. Other $174 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,583 44 payments
  2. Travel and Lodging $134 1 payment
Products named General payments · program years 2019–2025
  1. TheraSphere Y90 Glass Microspheres 10 GBq $307 3 payments
  2. Neuwave $282 4 payments
  3. Athletis $157 1 payment
  4. APBS $150 3 payments
  5. Indigo System $146 2 payments
  6. Cook Medical Self-Expanding Stent $123 1 payment
  7. GENERAL - VASCULAR INTERVENTION $110 1 payment
  8. AFFIRM $90 1 payment
  9. Azur CX Detachable $76 1 payment
  10. PROGREAT $76 1 payment
  11. Other $614 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

11

Median for Diagnostic Radiology: 24

Drug cost

$26

Median for Diagnostic Radiology: $190

Branded share of claims

0%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Naproxen Generic 11 $26

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 262 billing codes

Paid by Medicare

$180,117

Of which drugs: $2,034

Medicare patients

1,470

Average age 74

Services billed

18,691

848 women, 622 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 52%
Diabetes 31%
Ischemic heart disease 31%
Chronic kidney disease 25%
COPD 25%
Heart failure 23%
Atrial fibrillation 23%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 140 15,160 $1,618
Injection, gadobutrol, 0.1 ml A9585 Office 11 860 $233

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

45 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Wyoming

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record